In CRC, the common canonical gain-of-function mutation is the oncogenic mutation of Kirsten rat sarcoma viral oncogene homolog (KRAS) that encodes GTPases, namely, KRAS4A and KRAS4B [8]. Here, KRAS is linked to colorectal carcinoma.